Sign in
8-K

Current Report

SAB Biotherapeutics, Inc. Filed Acc 0001437749-23-010220

Regulation FD disclosure

  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading sabs20230413_8k.htm…